Medicilon/MPI Preclinical Research-Shanghai Celebrates its Grand Opening {October 17, 2008} Medicilon/MPI Preclinical Research-Shanghai is pleased to announce the Grand
Opening of its new preclinical research facility. The two parent companies, Shanghai Medicilon and MPI
Research, are equally represented in this new joint venture. The 50,000ft2 building is located in the
Chuansha Economic Park in Shanghai, China. This new facility will meet the regulatory standards set forth
by the US FDA and other regulatory agencies worldwide.
Medicilon/MPI Preclinical Research Shanghai Introduces Board of Directors
Mattawan, MI (April 2008) - Medicilon/MPI Preclinical Research Shanghai has announced its newly formed Board of Directors, which has equal representation from the two parent companies. The four directors include executives William U. Parfet and William Harrison from MPI Research, and Drs. Chun-Lin Chen and Jintao Zhang from Medicilon.
